Agnieszka Kotlarz

Agnieszka Kotlarz


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KKKonrad Kaminiów
Konrad Kaminiów
AKAgnieszka Kotlarz
Agnieszka Kotlarz
MKMartyna Kiołbasa
Martyna Kiołbasa
MPMaciej Pastuszczak
Maciej Pastuszczak
Objectives: Maternal syphilis can lead to serious adverse pregnancy outcomes, including neonatal death. A 4-fold decline in blood non-treponemal titer at six months after the treatment of syphilis compared to the baseline is considered as an adequate serological response. However, the duration of normal human gestation does not allow the ascertainment of an adequate serological response. Aim: The aim of this study was to assess correlations between the lack of a 4-fold decrease in non-treponemal titer by delivery after syphilis treatment and fetal and newborns’ condition and serological outcomes. Methods: Fourteen pregnant patients (gestational age 16–22 weeks) diagnosed with early syphilis (secondary or latent) were treated with intramuscular benzathine penicillin and subsequently monitored clinically, serologically, and ultrasonographically at monthly intervals. Based on the non-treponemal test results at delivery, patients were stratified into two groups: those with a 4-fold decline in titers and those without such a decline. All newborns were clinically and serologically assessed for congenital syphilis at birth and then monitored until serological tests became negative. Results: Fifty percent of the included women did not achieve a 4-fold decline in non-treponemal titer by delivery. Patients from the group showing a 4-fold decline in RPR titer at delivery and those without such a decline did not differ in basic demographic and clinical characteristics or in ultrasound parameters used for fetal assessment. Based on the clinical and laboratory assessments of newborns on the day of delivery and during a 6-month follow-up, none were diagnosed with congenital syphilis or required treatment for syphilis. Conclusions: The lack of an adequate serological response to syphilis therapy by delivery among patients treated between 16 and 22 weeks of pregnancy does not appear to be associated with adverse fetal and neonatal outcomes.

14 July 2026 in Ginekologia Polska
Verified
Journal Article
Closed access
KLKarolina Len-Gemel
Karolina Len-Gemel
AKAgnieszka Kotlarz
Agnieszka Kotlarz
KPKazimierz Pitynski
Kazimierz Pitynski
Growing teratoma syndrome (GTS) is a rare condition classically associated with platinum-based chemotherapy for malignant ovarian germ cell tumors. However, post-treatment findings following ovarian immature teratoma may represent a broader spectrum of entities that mimic recurrent malignancy and create substantial diagnostic challenges. Given the rarity of these conditions and their diverse clinical presentations, we present two illustrative cases managed at the Department of Gynecology and Gynecologic Oncology, University Hospital in Cracow, and review of the available literature. The first case involved a patient with ovarian immature teratoma who developed a classical post-chemotherapy GTS requiring surgical resection. During follow-up, a subsequent suspicious lesion demonstrated increased metabolic activity on positron emission tomography and was associated with mildly elevated tumor markers, raising concern for recurrent disease. Histopathological examination ultimately revealed a foreign-body granulomatous reaction. The second case involved a patient treated surgically for ovarian immature teratoma without adjuvant chemotherapy who subsequently developed peritoneal gliomatosis coexisting with deep infiltrating endometriosis, initially raising suspicion of intraperitoneal dissemination. These cases highlight the broad spectrum of post-treatment manifestations that may occur following ovarian immature teratoma. Enlarging masses, peritoneal implants, metabolically active lesions, and elevated tumor markers do not necessarily indicate malignant recurrence. Accurate diagnosis frequently requires correlation of imaging findings with surgical and histopathological assessment, and awareness of these rare entities is essential for appropriate management and surveillance.